World News

High Powered Labs Feud Over Gene-Editing Technology Patent – Bloomberg Law

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Americas+1 212 318 2000
EMEA+44 20 7330 7500
Asia Pacific+65 6212 1000
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Americas+1 212 318 2000
EMEA+44 20 7330 7500
Asia Pacific+65 6212 1000
By Michael Shapiro
The Federal Circuit signaled discomfort with a 2022 administrative ruling that gave a Massachusetts medical research organization an edge in its race to secure a potentially lucrative patent on a genetic-editing invention.
Judge Todd M. Hughes pressed the parties at an oral argument Tuesday about whether the Patent Trial and Appeal Board misapplied a legal test for determining when an invention is conceived. That decision rejected arguments from two Nobel Prize-winning scientists that they nailed down the invention first.
The dispute between the Broad Institute and the University of California, University of Vienna, and French scientist Emmanuelle Charpentier, hinges on …
AI-powered legal analytics, workflow tools and premium legal & business news.
Log in to keep reading or access research tools.

source

content single